日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Evolution of mast cell research associated with the Laboratory of Allergic Diseases, 1985-2022: Summary of the 2023 NIAID Symposium

1985-2022年与过敏性疾病实验室相关的肥大细胞研究发展历程:2023年NIAID研讨会总结

Komarow, Hirsh D; Nilsson, Gunnar; Okayama, Yoshimichi; Mekori, Yoseph; Olivera, Ana; Valent, Peter; Hartmann, Karin; Brockow, Knut; Cruse, Glenn; Lyons, Jonathan; Klion, Amy D; Akin, Cem; Gotlib, Jason R; Castells, Mariana; Galli, Stephen J; Metcalfe, Dean D; Carter, Melody C

Long-term survival can be achieved in a significant fraction of older patients with core-binding factor acute myeloid leukemia treated with intensive chemotherapy

对于接受强化化疗的患有核心结合因子急性髓系白血病的老年患者,相当一部分人可以获得长期生存。

Mosna, Federico; Borlenghi, Erika; Litzow, Mark; Byrd, John C; Papayannidis, Cristina; Tecchio, Cristina; Ferrara, Felicetto; Marcucci, Guido; Cairoli, Roberto; Morgan, Elizabeth A; Gurrieri, Carmela; Yeung, Cecilia C S; Deeg, H Joachim; Capelli, Debora; Candoni, Anna; Gotlib, Jason R; Lunghi, Monia; Pullarkat, Sheeja; Lanza, Francesco; Galimberti, Sara; Forghieri, Fabio; Venditti, Adriano; Festuccia, Moreno; Audisio, Ernesta; Marvalle, Denise; Rigolin, Gian Matteo; Roti, Giovanni; DiBona, Eros; Visani, Giuseppe; Albano, Francesco; Eisfeld, Ann-Kathrin; Valent, Peter; Huls, Gerwin; Borthakur, Gautam; Krampera, Mauro; Martinelli, Giovanni; Kröger, Nicolaus; Sperotto, Alessandra; Gottardi, Michele

Longitudinal study of 2 patients with cyclic thrombocytopenia, STAT3 and MPL mutations.

对 2 例患有周期性血小板减少症、STAT3 和 MPL 突变的患者进行纵向研究

Zhang Haiyu, Chien May, Hou Yu, Shomali William, Brar Rondeep S, Ho Chandler, Han Panpan, Xu Danfei, Zhang Bing M, Guo Xiangqian, Tolentino Lorna L, Wu Nancy C, Tsai Albert G, Jin Jing, Witteles Wesley H, Chen Zhenping, Abidi Parveen, Jangam Diwash, Krieger Madison S, Craig Morgan, Bussel James B, Gotlib Jason R, Zehnder James L

Predictive models for splenic response to JAK-inhibitor therapy in patients with myelofibrosis

骨髓纤维化患者脾脏对JAK抑制剂治疗反应的预测模型

Menghrajani, Kamal; Boonstra, Philip S; Mercer, Jessica A; Perkins, Cecelia; Gowin, Krisstina L; Weber, Alissa A; Mesa, Ruben; Gotlib, Jason R; Wang, Lixia; Singer, Jack W; Talpaz, Moshe

Impact of somatic and germline mutations on the outcome of systemic mastocytosis

体细胞和生殖细胞突变对系统性肥大细胞增生症预后的影响

Muñoz-González, Javier I; Jara-Acevedo, María; Alvarez-Twose, Iván; Merker, Jason D; Teodosio, Cristina; Hou, Yanli; Henriques, Ana; Roskin, Krishna M; Sanchez-Muñoz, Laura; Tsai, Albert G; Caldas, Carolina; Matito, Almudena; Sánchez-Gallego, J Ignacio; Mayado, Andrea; Dasilva-Freire, Noelia; Gotlib, Jason R; Escribano, Luis; Orfao, Alberto; García-Montero, Andrés C

Treatment With JAK Inhibitors in Myelofibrosis Patients Nullifies the Prognostic Impact of Unfavorable Cytogenetics

在骨髓纤维化患者中,JAK抑制剂治疗可消除不良细胞遗传学预后的影响

Ma, Vincent T; Boonstra, Philip S; Menghrajani, Kamal; Perkins, Cecelia; Gowin, Krisstina L; Mesa, Ruben A; Gotlib, Jason R; Talpaz, Moshe

Next-generation sequencing of acute myeloid leukemia identifies the significance of TP53, U2AF1, ASXL1, and TET2 mutations

新一代测序技术揭示了急性髓系白血病中TP53、U2AF1、ASXL1和TET2突变的重要性

Ohgami, Robert S; Ma, Lisa; Merker, Jason D; Gotlib, Jason R; Schrijver, Iris; Zehnder, James L; Arber, Daniel A

Phase II evaluation of IPI-926, an oral Hedgehog inhibitor, in patients with myelofibrosis

IPI-926(一种口服 Hedgehog 抑制剂)在骨髓纤维化患者中的 II 期评估

Sasaki, Koji; Gotlib, Jason R; Mesa, Ruben A; Newberry, Kate J; Ravandi, Farhad; Cortes, Jorge E; Kelly, Patrick; Kutok, Jeffery L; Kantarjian, Hagop M; Verstovsek, Srdan

Sequential azacitidine plus lenalidomide combination for elderly patients with untreated acute myeloid leukemia

序贯使用阿扎胞苷联合来那度胺治疗老年未治疗急性髓系白血病患者

Pollyea, Daniel A; Zehnder, James; Coutre, Steve; Gotlib, Jason R; Gallegos, Leonel; Abdel-Wahab, Omar; Greenberg, Peter; Zhang, Bing; Liedtke, Michaela; Berube, Caroline; Levine, Ross; Mitchell, Beverly S; Medeiros, Bruno C

Phase I trial of a novel human monoclonal antibody mAb216 in patients with relapsed or refractory B-cell acute lymphoblastic leukemia

一项针对复发或难治性B细胞急性淋巴细胞白血病患者的新型人源单克隆抗体mAb216的I期临床试验

Liedtke, Michaela; Twist, Clare J; Medeiros, Bruno C; Gotlib, Jason R; Berube, Caroline; Bieber, Marcia M; Bhat, Neelima M; Teng, Nelson N; Coutre, Steven E